Research programme: Ras pathway modulators - Morphochem
Alternative Names: MCP1; Ras pathway modulators research programme - MorphochemLatest Information Update: 28 Jul 2010
At a glance
- Originator Fox Chase Cancer Center; Morphochem AG
- Class Small molecules
- Mechanism of Action Ras signal transduction pathway modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 28 Jul 2010 Discontinued - Preclinical for Cancer in Germany (unspecified route)
- 28 Jul 2010 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 01 Dec 2005 Morphochem AG has been acquired by Biovertis AG